TABLE 2.

Characteristics of Occult Malignancies Identified in Study Patients

	Cancer
Patient	Localization	Stage	Histology	Interval between VTE diagnosis and detection of occult cancer, d
1	Biliary tract	IV	Adenocarcinoma	341
2	Pleura	IV	Adenocarcinoma	73
3	Acute myeloblastic leukemia	—	—	93
4	Hepatocellular carcinoma	IA	Clear cell component	264
5	Colon	IIA	Adenocarcinoma	151
6	Lung	IV	Adenocarcinoma	261
7	Prostate	IV	Adenocarcinoma	34
8	Bladder	IIIB	Squamous differentiation	31
9	Colon	IV	Adenocarcinoma	48
10	Prostate	IIA	Adenocarcinoma	85
11	Uterus	IIIB	Adenocarcinoma	38
12	Colon	IIA	Adenocarcinoma	106
13	Lung	IIIB	Adenocarcinoma	43
14	Uterus	IIA	Adenocarcinoma	79
15	Colon	IIA	Adenocarcinoma	429
16	Lung	IIB	Adenocarcinoma	114
17	Prostate	IIA	Adenocarcinoma	38
18	Lung	IIA	Adenocarcinoma	112
19	Multiple myeloma	IIIA		142

VTE, venous thromboembolism.